Additional Proxy Soliciting Materials (definitive) (defa14a)
April 28 2015 - 3:32PM
Edgar (US Regulatory)
SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
(Amendment No. )
Filed by the
Registrant x Filed by
a Party other than the Registrant ¨
Check the appropriate box:
|
|
|
¨ |
|
Preliminary Proxy Statement |
|
|
¨ |
|
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
|
|
¨ |
|
Definitive Proxy Statement |
|
|
x |
|
Definitive Additional Materials |
|
|
¨ |
|
Soliciting Material Pursuant to § 240.14a-12 |
SUNESIS
PHARMACEUTICALS, INC.
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement if Other Than the Registrant)
Payment of Filing Fee (Check the appropriate box)
|
|
|
|
|
|
|
x |
|
No fee required. |
|
|
¨ |
|
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. |
|
|
|
|
|
1. |
|
Title of each class of securities to which transaction applies:
|
|
|
2. |
|
Aggregate number of securities to which transaction applies:
|
|
|
3. |
|
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11
(Set forth the amount on which the filing fee is calculated and state how it was determined):
|
|
|
4. |
|
Proposed maximum aggregate value of transaction:
|
|
|
5. |
|
Total fee paid:
|
|
|
¨ |
|
Fee paid previously with preliminary materials. |
|
|
¨ |
|
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement
number, or the Form or Schedule and the date of its filing. |
|
|
|
|
|
6. |
|
Amount Previously Paid:
|
|
|
7. |
|
Form, Schedule or Registration Statement No.:
|
|
|
8. |
|
Filing Party:
|
|
|
9. |
|
Date Filed:
|
***
Exercise Your Right to Vote ***
Important Notice Regarding the Availability of Proxy Materials for the
Stockholder Meeting to Be Held on June 8, 2015.
SUNESIS PHARMACEUTICALS, INC.
Meeting Information
Meeting Type: Annual Meeting
For holders as of:
April 10, 2015
Date: June 8, 2015 Time: 10:00 A.M. (Pacific)
Location: 395 Oyster Point Boulevard Suite 400 South San Francisco, CA 94080
SUNESIS PHARMACEUTICALS, INC. 395 OYSTER POINT BLVD.
SUITE 400
SOUTH SAN FRANCISCO, CA 94080
You are receiving
this communication because you hold shares in the company named above.
This is not a ballot. You cannot use
this notice to vote these shares. This communication presents only an overview of the more complete proxy materials that are available to you on the Internet. You may view the proxy materials online at www.proxyvote.com or easily request a paper
copy (see reverse side).
We encourage you to access and review all of the important information contained in
the proxy materials before voting.
M88165-P61536
How to
Before Access the You Proxy Vote Materials
Proxy Materials Available to VIEW or RECEIVE:
NOTICE OF MEETING ANNUAL REPORT ON FORM 10-K PROXY STATEMENT
How to View Online:
Have the information that is printed in the box marked by the arrow XXXX XXXX XXXX XXXX (located on the following page) and visit: www.proxyvote.com.
How to Request and Receive a PAPER or E-MAIL Copy:
If you want to receive a paper or e-mail copy of these documents, you must request one. There is NO charge for requesting
a copy. Please choose one of the following methods to make your request: 1) BY INTERNET: www.proxyvote.com 2) BY TELEPHONE: 1-800-579-1639 3) BY E-MAIL*: sendmaterial@proxyvote.com
* If requesting materials by e-mail, please send a blank e-mail with the information that is printed in the box marked by
the arrowXXXX XXXX XXXX XXXX (located on the following page) in the subject line.
Requests, instructions and
other inquiries sent to this e-mail address will NOT be forwarded to your investment advisor. Please make the request as instructed above on or before May 25, 2015 to facilitate timely delivery.
How To Vote
Please Choose One of the Following Voting Methods
Vote In Person: Many stockholder meetings have attendance requirements including, but not limited to, the possession of an
attendance ticket issued by the entity holding the meeting. Please check the meeting materials for any special requirements for meeting attendance. At the meeting, you will need to request a ballot to vote these shares. Vote By Internet: To vote now
by Internet, go to www.proxyvote.com. Have the information that is printed in the box marked by the arrowXXXX XXXX XXXX XXXX (located on the following page) available and follow the instructions. Vote By Mail: You can vote by mail by requesting a
paper copy of the materials, which will include a proxy card.
M88166-P61536
Voting
Items
The Board of Directors recommends you vote FOR the following: Vote on Directors
1. To elect the three nominees for director named below to hold office as Class I members of the Board of Directors until
the 2018 annual meeting of stockholders
Nominees:
01) Steve R. Carchedi 02) Helen S. Kim 03) Dayton Misfeldt
The Board of Directors recommends you vote FOR the following proposal:
2. To approve, on an advisory basis, the compensation of our named executive officers.
The Board of Directors recommends you vote FOR the following proposal:
3. To ratify the selection of Ernst & Young LLP as the independent registered public accounting firm of Sunesis
for the year ending December 31, 2015.
NOTE: Such other business as may properly come before the meeting
or any adjournment thereof.
M88167-P61536
M88168-P61536
Sunesis Pharmaceuticals (NASDAQ:SNSS)
Historical Stock Chart
From Jul 2024 to Aug 2024
Sunesis Pharmaceuticals (NASDAQ:SNSS)
Historical Stock Chart
From Aug 2023 to Aug 2024